Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy

Observational/retrospective studies indicate that prostaglandin-endoperoxide synthase-2 (PTGS2) inhibitors could positively affect colorectal cancer (CRC) patients’ survival after diagnosis. To obtain an acceptable cost/benefit balance, the inclusion of PTGS2 inhibitors in the adjuvant setting needs...

Descripción completa

Detalles Bibliográficos
Autores principales: Venè, Roberta, Costa, Delfina, Augugliaro, Raffaella, Carlone, Sebastiano, Scabini, Stefano, Casoni Pattacini, Gianmaria, Boggio, Maurizio, Zupo, Simonetta, Grillo, Federica, Mastracci, Luca, Pitto, Francesca, Minghelli, Simona, Ferrari, Nicoletta, Tosetti, Francesca, Romairone, Emanuele, Mingari, Maria C., Poggi, Alessandro, Benelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140631/
https://www.ncbi.nlm.nih.gov/pubmed/32168749
http://dx.doi.org/10.3390/cells9030683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140631/
https://www.ncbi.nlm.nih.gov/pubmed/32168749
http://dx.doi.org/10.3390/cells9030683

Ejemplares similares